Novartis / Immunovaccine Inc. / HISTORY AND STRATEGY History The Company / COMPANY OVERVIEW Immunovaccine / Merck KGaA / Roche / Dendreon / GlaxoSmithKline / US National Institutes of Health / Johnson & Johnson Merck & Co. / Sanofi / Bristol-Myers Squibb / Merck & Co. / Weill Cornell Medical College / TSX Venture Exchange / Pfizer Animal Health / CSL Limited / Sanofi Pasteur / /
Continent
Europe / North America / /
Country
Canada / United States / /
Currency
USD / /
Event
Business Partnership / FDA Phase / M&A / Funding / /
Facility
Weill Cornell Medical College / Dalhousie University / NIH’s National Institute of Allergy / Canadian Institute of Chartered Accountants / National Cancer Institute / /
IndustryTerm
manufacturing facility / human applications / pharmaceutical industry / cancer therapy / platform technology / vaccine products / manufacturing processes / vaccine delivery technology / manufacturing process / treatment of cancer / contract manufacturing formulation / manufacturing / healthcare providers / livestock vaccine applications / animal health vaccine applications / biotechnology / delivery technology / oil phase / cancer treatment / pharmaceutical / healthcare / oil / product-specific manufacturing process / infectious diseases treatment / sterile products / treatment of multiple solid tumors and hematological cancers / scale manufacturing process / contract manufacturing facility / enhancement technology / /
MedicalCondition
ovarian cancer / yellow fever / H5N1 pandemic influenza / cocaine abuse / diphtheria / infectious and other diseases / therapeutic cancer / hepatitis B / melanoma / injury / prostate cancer / breast cancer / glioblastoma / tumor / Conventional cancer / cancer / tumors / malaria / difficult infectious and other disease / cocaine addiction / plague / diseases / melioidosis / ovarian and prostate cancer / dengue / pancreatic / multiple myeloma / anthrax / hematological cancers / drug addiction / Therapeutic cancer vaccines Cancer / flu / advanced ovarian cancer / solid tumors / widespread and prevalent diseases / influenza / several cancers / disease / Viral disease / critical tumor / infectious diseases / meningitis / B-cell lymphoma / Several first-in-class therapeutic cancer / /
MedicalTreatment
vaccination / surgery / immunotherapy / radiation / cancer therapy / contraception / immunization / chemotherapy / /
Organization
US Advisory Committee on Immunization Practices / National Institute on Drug Abuse / Department of Fisheries and Oceans / Canadian Institute of Chartered Accountants / Dalhousie University / National Cancer Institute / National Institute of Health / NIH’s National Institute of Allergy and Infectious Diseases / Cornell / Congress / International Accounting Standards Board / Scientific Advisory Board / US Food and Drug Administration / Atlantic Canada Opportunities Agency / Department of Defense / Weill Cornell Medical College / US Centers for Disease Control and Prevention / /
Person
John Trizzino / Weill Cornell / /
Position
CEO 1 MANAGEMENT / scientific advisors / investigator / /
Microsoft Word - Q1 - MD&A final filed